Bluejay Diagnostics reported earnings of -$ 1.72 per BJDX share on Nov 12, 2026, falling short of analysts' expectations by
| Report Date | Nov 12, 2026 |
|---|---|
| Forecasted EPS | -$ 3,520.00 |
| Earnings Per Share (Surprise) | -$ 1.72 (+$ 3,518.28) |
| Last Year's EPS | -$ 102.12 |
| EPS YoY Change |
Out of the last 28 earnings reporting periods, Bluejay Diagnostics beat analysts’ expectations 8 times and fell short of expectations 9 time(s). Bluejay Diagnostics reported earnings per share of -$ 1.72 in the last report surpassing an estimated EPS of -$ 3,520.00 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 12, 2026 | -$ 3,520.00 | -$ 1.72 | -$ 64.64 | |
| Aug 12, 2026 | -$ 56,320 | -$ 17.92 | -$ 90.24 | |
| May 13, 2026 | - | -$ 31.20 | -$ 215.68 | |
| Mar 6, 2026 | - | -$ 37.92 | -$ 7,191.68 | |
| Nov 7, 2025 | - | -$ 64.64 | -$ 512.00 | |
| Aug 7, 2025 | -$ 2,304.00 | -$ 90.24 | -$ 16,384 | |
| May 13, 2025 | -$ 18,432 | -$ 215.68 | -$ 6,336.00 | |
| Mar 31, 2025 | -$ 13,312 | -$ 7,191.68 | -$ 61,440 | |
| Nov 7, 2024 | -$ 20,864 | -$ 512.00 | -$ 45,568 | |
| Aug 14, 2024 | -$ 2,304.00 | -$ 16,384 | -$ 53,248 | |
| May 15, 2024 | -$ 18,432 | -$ 6,336.00 | -$ 70,400 | |
| May 8, 2024 | -$ 30,720 | -$ 61,440 | -$ 61,440 | |
| Mar 28, 2024 | -$ 10.88 | -$ 45,568 | -$ 61,440 | |
| Nov 9, 2023 | -$ 13.12 | -$ 53,248 | -$ 384.00 | |
| Aug 14, 2023 | -$ 24.00 | -$ 70,400 | -$ 512.00 | |
| May 10, 2023 | -$ 30,720 | -$ 61,440 | -$ 51,200 | |
| Mar 20, 2023 | $ 0.64 | -$ 61,440 | -$ 46,080 | |
| Nov 9, 2022 | -$ 1.28 | -$ 384.00 | -$ 626.56 | |
| Jul 26, 2022 | -$ 409.60 | -$ 512.00 | -$ 390.07 | |
| Apr 20, 2022 | -$ 56,320 | -$ 51,200 | -$ 157.96 |
Bluejay Diagnostics’s stock was trading at $ 2.80 on Nov 11, 2026 a day before the last earnings report was released.Following the release of the earnings report, BJDX’s price decreased to $ 2.61 on Nov 13, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 12, 2026 | -$ 1.72 | $ 2.80 | $ 2.61 | |
| Aug 12, 2026 | -$ 17.92 | $ 17.12 | $ 16.96 | |
| May 13, 2026 | -$ 31.20 | $ 28.64 | $ 28.00 | |
| Mar 6, 2026 | -$ 37.92 | $ 30.40 | $ 29.92 | |
| Nov 7, 2025 | -$ 64.64 | $ 101.76 | $ 100.48 | |
| Aug 7, 2025 | -$ 90.24 | $ 94.08 | $ 89.60 | |
| May 13, 2025 | -$ 215.68 | $ 113.92 | $ 109.44 | |
| Mar 31, 2025 | -$ 7,191.68 | $ 243.84 | $ 231.68 | |
| Nov 7, 2024 | -$ 512.00 | $ 294.40 | $ 291.20 | |
| Aug 14, 2024 | -$ 16,384 | $ 1,068.80 | $ 979.20 | |
| May 15, 2024 | -$ 6,336.00 | $ 14,080 | $ 14,720 | |
| May 8, 2024 | -$ 61,440 | $ 13,315 | $ 13,056 | |
| Mar 28, 2024 | -$ 45,568 | $ 20,582 | $ 19,738 | |
| Nov 9, 2023 | -$ 53,248 | $ 84,736 | $ 85,248 | |
| Aug 14, 2023 | -$ 70,400 | $ 206,080 | $ 193,536 | |
| May 10, 2023 | -$ 61,440 | $ 145,920 | $ 153,651 | |
| Mar 20, 2023 | -$ 61,440 | $ 267,571 | $ 230,451 | |
| Nov 9, 2022 | -$ 384.00 | $ 404,403 | $ 371,712 | |
| Jul 26, 2022 | -$ 512.00 | $ 637,440 | $ 593,920 | |
| Apr 20, 2022 | -$ 51,200 | $ 482,816 | $ 503,719 |
Bluejay Diagnostics released its most recent earnings reports in November 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Bluejay Diagnostics beat analysts’ expectations during the last earnings period by
